亚太地区基于电动车的液体活体组织切片市场：分析与预测（2023-2032）

亚太地区基于电动车的液体活体组织切片市场规模预计将从 2023 年的 1,282 万美元增至 2032 年的 7,475 万美元，预测期内复合年增长率为 21.64%。

预计该市场将在技术不断进步、医疗保健提供者的接受度不断提高以及对个人化医疗方法的日益重视的推动下增长。

亚太地区基于电动车的液体活体组织切片市场正在经历显着成长。这一增长主要归功于医疗技术的持续进步以及全部区域医疗保健提供者越来越多地采用液体活体组织切片技术。液体活体组织切片正在成为一种用于早期检测癌症和监测治疗效果的非侵入性方法，这与该地区医疗保健环境中对个人化医疗日益增长的兴趣相吻合。由于研发活动激增以及将先进技术引入医疗保健系统，中国、日本和韩国等国家处于这一趋势的前沿。此外，该地区庞大且多样化的人口为液体活体组织切片应用提供了丰富的患者群。因此，该地区的市场将显着成长，并为公司和相关利益者提供利润丰厚的机会。

本报告调查了亚太地区基于电动车的液体活体组织切片市场，并提供了市场概况、市场成长的各种影响因素分析、市场规模趋势和预测、主要国家的详细分析以及主要企业的分析。我正在总结。

市场分类

细分 1：按国家/地区

• 中国
• 日本
• 韩国
• 澳洲
• 印度
• 新加坡
• 其他的

目录

执行摘要

第一章 研究范围

第二章调查方法

第三章市场概况

• 市场概况
• 基于EV的液体活体组织切片的现状和未来
• 目前的市场规模和成长潜力
• COVID-19 对基于 EV 的液体活体组织切片市场的影响

第4章 EV隔离与分析方法

• 概述
• 分离方法
  • 使用超速离心的 EV 分离技术
  • 使用基于尺寸的方法的EV分离技术
  • 采用亲和性和法的EV分离技术
  • 采用沉淀法的EV分离技术
  • 利用微流控技术的EV分离技术
  • 使用市售套件的 EV 隔离技术
  • EV隔离方法的优点和缺点
  • 胞外体分离的新方法
• 分析方法
  • EV分析方法的优缺点

第五章 EV液体活体组织切片市场（按地区）

• 概述
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 韩国
  • 澳洲
  • 新加坡
  • 其他的

第六章 公司简介

• 公司简介

“The Asia-Pacific EV-Based Liquid Biopsy Market Expected to Reach $74.75 Million by 2032.”

Introduction to Asia-Pacific EV-Based Liquid Biopsy Market

The Asia-Pacific EV-based liquid biopsy market is expected to reach $74.75 million by 2032 from $12.82 million in 2023, at a CAGR of 21.64% during the forecast period. The market for EV-based liquid biopsy is anticipated to see growth propelled by continuous technological progress, rising acceptance by healthcare providers, and an increasing emphasis on personalized medical approaches.

Market Introduction

The Asia-Pacific (APAC) region is witnessing significant growth in the EV-based liquid biopsy market. This expansion is primarily attributed to ongoing advancements in healthcare technology and the increasing adoption of liquid biopsy techniques by healthcare providers across the region. Liquid biopsies are gaining prominence as a non-invasive method for early cancer detection and monitoring treatment response, aligning with the growing focus on personalized medicine in the APAC healthcare landscape. Countries like China, Japan, and South Korea are at the forefront of this trend, with a surge in research and development activities and the incorporation of advanced technologies into healthcare systems. Additionally, the region's large and diverse population offers a substantial patient pool for liquid biopsy applications. As a result, the APAC EV-based liquid biopsy market is poised for significant growth, presenting lucrative opportunities for healthcare companies and stakeholders in the region's dynamic healthcare sector.

Market Segmentation:

Segmentation 1: by Country

• China
• Japan
• South Korea
• Australia
• India
• Singapore
• Rest-of-Asia-Pacific

How can this report add value to an organization?

Growth/Marketing Strategy: EV-based liquid biopsy has tremendous growth potential due to its ability to revolutionize non-invasive cancer detection and monitoring. By analyzing the cargo of EVs, researchers can gain insights into the presence, type, and characteristics of tumors without directly accessing the tumor site.

Competitive Strategy: Key players in the APAC EV-based liquid biopsy market have been analyzed and profiled in the study, including manufacturers. Moreover, a detailed competitive benchmarking of the players operating in the APAC EV-based liquid biopsy market has been done to help the reader understand how players stack against each other, presenting a clear market landscape.

Table of Contents

Executive Summary

1. Research Scope

• 1.1. Key Questions Answered in the Report:

2. Research Methodology

• 2.1. EV-Based Liquid Biopsy Market: Research Methodology
• 2.2. Primary Data Sources
• 2.3. Secondary Data Sources
• 2.4. Market Estimation Model
• 2.5. Criteria for Company Profiling

3. Markets Overview

• 3.1. Market Introduction
• 3.2. Current and Future State of EV-Based Liquid Biopsy in Industries
• 3.3. Current Market Size and Growth Potential, $Million, 2022-2032
• 3.4. COVID-19 Impact on EV-based Liquid Biopsy Market
  • 3.4.1. Impact on Operations
  • 3.4.2. COVID-19 Impact: Current Scenario of the Market

4. Methods of EV Isolation and Analysis

• 4.1. Overview
  • 4.1.1. Evs Introduction
• 4.2. Isolation Methods
  • 4.2.1. EV Isolation Techniques Utilizing Ultracentrifugation Methods
    • 4.2.1.1. Differential Ultracentrifugation
    • 4.2.1.2. Density Gradient Centrifugation
    • 4.2.1.3. Moving Zone or Rate-Zonal Centrifugation
    • 4.2.1.4. Isopycnic Centrifugation
  • 4.2.2. EV Isolation Techniques Utilizing Size-Based Methods
    • 4.2.2.1. Ultrafiltration
    • 4.2.2.2. Sequential Filtration
    • 4.2.2.3. Size Exclusion Chromatography (SEC)
    • 4.2.2.4. Flow Field-Flow Fractionation (FFFF)
    • 4.2.2.5. Hydrostatic Filtration Dialysis (HFD)
  • 4.2.3. EV Isolation Techniques Utilizing Immunoaffinity Methods
    • 4.2.3.1. Enzyme-Linked Immunosorbent Assay (ELISA)
    • 4.2.3.2. Magneto-Immunoprecipitation
  • 4.2.4. EV Isolation Techniques Utilizing Precipitation Methods
    • 4.2.4.1. Polyethylene Glycol (PEG) Precipitation
    • 4.2.4.2. Lectin Induced Agglutination
  • 4.2.5. EV Isolation Techniques Utilizing Microfluidic Technology
  • 4.2.6. EV Isolation Techniques Utilizing Commercial Kits
  • 4.2.7. Advantages and Disadvantages of the EV Isolation Methods
  • 4.2.8. Novel Approaches for Exosome Isolation
• 4.3. Analysis Methods
  • 4.3.1. Advantages and Disadvantages of Analysis Methods for Evs

5. EV-Based Liquid Biopsy Market (by Region), $Million, 2022-2032

• 5.1. Overview
• 5.2. Asia-Pacific
  • 5.2.1. China
  • 5.2.2. Japan
  • 5.2.3. India
  • 5.2.4. South Korea
  • 5.2.5. Australia
  • 5.2.6. Singapore
  • 5.2.7. Rest-of-Asia-Pacific

6. Company Profiles

• 6.1. Company Overview
  • 6.1.1. Horiba Ltd.
    • 6.1.1.1. Company Overview
    • 6.1.1.2. Role of Horiba Ltd. in the EV-Based Liquid Biopsy Market
    • 6.1.1.3. Major Products: Key Specifications
    • 6.1.1.4. Key Competitors
    • 6.1.1.5. Analyst Perspective
  • 6.1.2. Takara Bio Inc.
    • 6.1.2.1. Company Overview
    • 6.1.2.2. Role of Takara Bio Inc. in the EV-Based Liquid Biopsy Market
    • 6.1.2.3. Major Products: Key Specifications
    • 6.1.2.4. Key Competitors
    • 6.1.2.5. Analyst Perspective

List of Figures

• Figure 1: EV-Based Liquid Biopsy Market (by Region), 2022
• Figure 2: EV-Based Liquid Biopsy Market Methodology
• Figure 3: Primary Research Methodology
• Figure 4: Bottom-Up Approach (Segment-Wise Analysis)
• Figure 5: Top-Down Approach (Segment-Wise Analysis)
• Figure 6: Asia-Pacific EV-Based Liquid Biopsy Market, $Million, 2022-2032
• Figure 7: Subtypes of Evs
• Figure 8: Methods of EV-Isolation from Biofluids
• Figure 9: Workflow of Differential Ultracentrifugation for Exosome Isolation
• Figure 10: Methods of EV-Analysis
• Figure 11: EV-Based Liquid Biopsy Market Snapshot (by Region)
• Figure 12: EV-Based Liquid Biopsy Market (by Region), $Million, 2022-2032
• Figure 13: Asia-Pacific EV-Based Liquid Biopsy Market, $Million, 2022-2032
• Figure 14: Asia-Pacific: Market Dynamics
• Figure 15: Asia-Pacific EV-Based Liquid Biopsy Market (by Country), $Million, 2022-2032
• Figure 16: China EV-Based Liquid Biopsy Market, $Million, 2022-2032
• Figure 17: Japan EV-Based Liquid Biopsy Market, $Million, 2022-2032
• Figure 18: India EV-Based Liquid Biopsy Market, $Million, 2022-2032
• Figure 19: South Korea EV-Based Liquid Biopsy Market, $Million, 2022-2032
• Figure 20: Australia EV-Based Liquid Biopsy Market, $Million, 2022-2032
• Figure 21: Singapore EV-Based Liquid Biopsy Market, $Million, 2022-2032
• Figure 22: Rest-of-Asia-Pacific EV-Based Liquid Biopsy Market, $Million, 2022-2032
• Figure 23: Total Number of Companies Profiled
• Figure 24: Horiba Ltd.: Product Portfolio
• Figure 25: Takara Bio Inc.: Product Portfolio

List of Tables

• Table 1: Current and Future State of EV-Based Liquid Biopsy in Industries
• Table 2: Example of Few Commercial Kits Available for EV Isolation
• Table 3: Advantages and Disadvantages of the EV Isolation Methods
• Table 4: Emerging Methods for the Isolation of Exosomes
• Table 5: Advantages and Disadvantages of Analysis Methods for Evs